|
|
 Previous Article | Table of Contents | Next Article 
Basic fibroblast growth factor stimulates myelopoiesis in long-term human
bone marrow cultures
EL Wilson, DB Rifkin, F Kelly, MJ Hannocks and JL Gabrilove
Department of Cell Biology, New York University Medical Center, NY 10016.
We previously showed that basic fibroblast growth factor (bFGF) is a potent
mitogen for human bone marrow (BM) stromal cells and significantly delays
their senescence. In the present study, we demonstrated that low
concentrations of bFGF (0.2 to 2 ng/mL) enhance myelopoiesis in long-term
human BM culture. Addition of bFGF to long- term BM cultures resulted in an
increase in (a) the number of nonadherent cells (sixfold), particularly
those of the neutrophil granulocyte series; (b) the number of nonadherent
granulocyte colony- stimulating factor (G-CSF)- and granulocyte-macrophage
colony- stimulating factor (GM-CSF)-responsive progenitor cells; (c) the
number of adherent foci of hematopoietic cells (10-fold); and (d) the
number of progenitor cells in the adherent stromal cell layer. These
effects were not noted with higher concentrations of bFGF (20 ng/mL). Thus,
low concentrations of bFGF effectively augment myelopoiesis in human long-
term BM cultures, and bFGF may therefore be a regulator of the
hematopoietic system in vitro and in vivo.
Volume 77,
Issue 5,
pp. 954-960,
03/01/1991
Copyright © 1991 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. J. Nemeth, K. K. Mak, Y. Yang, and D. M. Bodine
{beta}-Catenin Expression in the Bone Marrow Microenvironment Is Required for Long-Term Maintenance of Primitive Hematopoietic Cells
Stem Cells,
May 1, 2009;
27(5):
1109 - 1119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nakayama, N. Mutsuga, and G. Tosato
FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc
Blood,
February 15, 2007;
109(4):
1363 - 1372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nakayama, N. Mutsuga, and G. Tosato
Effect of Fibroblast Growth Factor 2 on Stromal Cell-Derived Factor 1 Production by Bone Marrow Stromal Cells and Hematopoiesis
J Natl Cancer Inst,
February 7, 2007;
99(3):
223 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Wamsley, U. T. Iwaniec, and T. J. Wronski
Selected Extraskeletal Effects of Systemic Treatment with Basic Fibroblast Growth Factor in Ovariectomized Rats
Toxicol Pathol,
August 1, 2005;
33(5):
577 - 583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J. D. Coffin, and M. M. Hurley
Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone
J. Biol. Chem.,
May 30, 2003;
278(23):
21258 - 21266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-M. Liu, F. Lawrence, M. Kovacevic, J. Bignon, E. Papadimitriou, J.-Y. Lallemand, P. Katsoris, P. Potier, Y. Fromes, and J. Wdzieczak-Bakala
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo
Blood,
April 15, 2003;
101(8):
3014 - 3020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Burger, S. Coetzee, W. L. McKeehan, M. Kan, P. Cook, Y. Fan, T. Suda, R. P. Hebbel, N. Novitzky, W. A. Muller, et al.
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells
Blood,
November 15, 2002;
100(10):
3527 - 3535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Inoue, T. E. King Jr., E. Barker, E. Daniloff, and L. S. Newman
Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis
Am. J. Respir. Crit. Care Med.,
September 1, 2002;
166(5):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Colin, J.-C. Jeanny, F. Mascarelli, R. Vienet, S. Al-Mahmood, Y. Courtois, and J. Labarre
In Vivo Involvement of Heparan Sulfate Proteoglycan in the Bioavailability, Internalization, and Catabolism of Exogenous Basic Fibroblast Growth Factor
Mol. Pharmacol.,
January 1, 1999;
55(1):
74 - 82.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Ortega, M. Ittmann, S. H. Tsang, M. Ehrlich, and C. Basilico
Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2
PNAS,
May 12, 1998;
95(10):
5672 - 5677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bruno, S. K. Horrigan, D. Van Den Berg, E. Rozler, P. R. Fitting, S. T. Moss, C. Westbrook, and R. Hoffman
The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-beta on Human Hematopoiesis
Blood,
March 15, 1998;
91(6):
1917 - 1923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin
Biological Roles of Fibroblast Growth Factor-2
Endocr. Rev.,
February 1, 1997;
18(1):
26 - 45.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Richard, J. P. Liuzzo, and D. Moscatelli
Fibroblast Growth Factor-2 Can Mediate Cell Attachment by Linking Receptors and Heparan Sulfate Proteoglycans on Neighboring Cells
J. Biol. Chem.,
October 13, 1995;
270(41):
24188 - 24196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
